Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Citigroup Maintains Buy on Abbott Laboratories, Raises Price Target to $125

Citigroup analyst Joanne Wuensch maintains Abbott Laboratories (NYSE:ABT) with a Buy and raises the price target from $114 to $125.
byBenzinga Newsdesk
December 12, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Citigroup analyst Joanne Wuensch maintains Abbott Laboratories (NYSE:ABT) with a Buy and raises the price target from $114 to $125.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0